
Drug of Abuse Testing Market by Component (Analyzers, Consumables, Laboratory Services), Sample Type (Blood, Hair, Oral Fluids), End User - Global Forecast 2024-2030
Description
Drug of Abuse Testing Market by Component (Analyzers, Consumables, Laboratory Services), Sample Type (Blood, Hair, Oral Fluids), End User - Global Forecast 2024-2030
The Drug of Abuse Testing Market size was estimated at USD 1.74 billion in 2023 and expected to reach USD 1.87 billion in 2024, at a CAGR 7.28% to reach USD 2.86 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Drug of Abuse Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug of Abuse Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Clinical Reference Laboratory, Inc., Danaher Corporation, Drgerwerk AG & Co. KGaA, Express Diagnostics International, F. Hoffmann-La Roche Ltd, GE Healthcare Inc., Laboratory Corporation of America Holdings, Legacy Healthcare Services, Inc., Mayo Collaborative Services, Inc., Merck KGaA, Pfizer Inc., Precision Diagnostic Services Inc, Psychemedics Corporation, Quest Diagnostics, Sanofi SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
Market Segmentation & Coverage
This research report categorizes the Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Component
Analyzers
Consumables
Laboratory Services
Rapid Testing Devices
Sample Type
Blood
Hair
Oral Fluids
Sweat
Urine
End User
Criminal Justice Systems & Law Enforcement Agencies
Hospitals
Research Laboratories
Workplace & School
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Drug of Abuse Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug of Abuse Testing Market?
3. What are the technology trends and regulatory frameworks in the Drug of Abuse Testing Market?
4. What is the market share of the leading vendors in the Drug of Abuse Testing Market?
5. Which modes and strategic moves are suitable for entering the Drug of Abuse Testing Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
183 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Drug of Abuse Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing demand for drug abuse treatment
- 5.1.1.2. Stringent law mandating alcohol and drug testing
- 5.1.1.3. Increasing drug-related mortality rate and government initiative
- 5.1.2. Restraints
- 5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
- 5.1.3. Opportunities
- 5.1.3.1. Introduction to innovative and user-friendly disposable products
- 5.1.3.2. Technological advancements in drug testing
- 5.1.4. Challenges
- 5.1.4.1. Possibilities of false-positive test
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Drug of Abuse Testing Market, by Component
- 6.1. Introduction
- 6.2. Analyzers
- 6.3. Consumables
- 6.4. Laboratory Services
- 6.5. Rapid Testing Devices
- 7. Drug of Abuse Testing Market, by Sample Type
- 7.1. Introduction
- 7.2. Blood
- 7.3. Hair
- 7.4. Oral Fluids
- 7.5. Sweat
- 7.6. Urine
- 8. Drug of Abuse Testing Market, by End User
- 8.1. Introduction
- 8.2. Criminal Justice Systems & Law Enforcement Agencies
- 8.3. Hospitals
- 8.4. Research Laboratories
- 8.5. Workplace & School
- 9. Americas Drug of Abuse Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Drug of Abuse Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Drug of Abuse Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Bio-Rad Laboratories, Inc.
- 13.1.3. Clinical Reference Laboratory, Inc.
- 13.1.4. Danaher Corporation
- 13.1.5. Drgerwerk AG & Co. KGaA
- 13.1.6. Express Diagnostics International
- 13.1.7. F. Hoffmann-La Roche Ltd
- 13.1.8. GE Healthcare Inc.
- 13.1.9. Laboratory Corporation of America Holdings
- 13.1.10. Legacy Healthcare Services, Inc.
- 13.1.11. Mayo Collaborative Services, Inc.
- 13.1.12. Merck KGaA
- 13.1.13. Pfizer Inc.
- 13.1.14. Precision Diagnostic Services Inc
- 13.1.15. Psychemedics Corporation
- 13.1.16. Quest Diagnostics
- 13.1.17. Sanofi SA
- 13.1.18. Siemens Healthineers AG
- 13.1.19. Thermo Fisher Scientific Inc
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
- FIGURE 2. DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DRUG OF ABUSE TESTING MARKET DYNAMICS
- FIGURE 7. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
- FIGURE 8. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
- FIGURE 10. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.